Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Aphria Inc. APHA

Aphria, which is headquartered in Ontario, produces and sells medicinal and recreational cannabis. The company operates through retail and wholesale channels in Canada and internationally. Aphria is a main distributor of medical cannabis to Germany and has operations in over 10 countries outside of Canada. However, it does not have exposure to the U.S. CBD or THC markets due to the constraints of federal prohibition. It has some U.S. exposure through the acquisition of SweetWater, a craft brewer


NDAQ:APHA - Post by User

Bullboard Posts
Comment by CentreIce24on Jan 25, 2020 11:48am
188 Views
Post# 30598448

RE:Hypothetical

RE:HypotheticalHey Plane1
Well Said...excellent commentary 
I was going to post but there is no need to do so now.
You pretty much covered most my points.
I AGREE, this time is DIFFERENT.
The change in investors sentiment towards Aphria is happening 
You can feel & smell it in the air
Only thing I will add is let's see what part 2 of this transaction is
I don't think it will take long until we find out

Have A Great Weekend
CentreIce 




Plane1 wrote:
It may come as a surprise, or not, to everyone here that the possible undisclosed investor may very well be Bayer, Monsanto or some other conglomerate dipping their toes in the water. I'm not claiming that it is. This is purely hypothetical as some posters have also proposed. Let's assume that if anyone of those companies mentioned invested 1 billion or 2 into Aphria. What would be the stock price today. I think we all know where it would be. But for how long and at what cost? Doesn't look like the share price of any of these other companies that have had cash infusions have faired any better. Shortly after EU GMP Certification a 100 million? Way to much of a coincidence. My point is, slow and steady wins the race people. Don't be quick to judge management. Yes, yes, I know. We do have a history. I hardly think the same mistakes will happen again. Long APHRIA!!!!!!


Bullboard Posts